Error message

The page you requested does not exist. For your convenience, a search was performed using the query news events press coverage 2018 03 03.

Page not found

You are here

Thu, October 29, 2015

Jeremy Sussman has received much press for a recent study in JAMA about rates of treatment deintensification in diabetes. Dr. Sussman is first author of a study that found that among older diabetes patients whose treatment resulted in very low blood pressure, only a minority (27% or fewer) underwent treatment deintensification for diabetes, which represents a lost opportunity to reduce overtreatment. The study suggests practice guidelines and performance measures should place more focus on reducing overtreatment through deintensification.

Tanner Caverly and other CBSSM faculty co-authored a national survey study in JAMA examining VA primary care health-care professionals' beliefs regarding prescribing for older diabetics. This study found misperceptions about the benefits of stringent blood glucose control and concerns about negative repercussions following deintensification of therapy. This study is also being cited in a number of press articles.

Original studies:

Sussman, Jeremy B., Eve A. Kerr, Sameer D. Saini, Rob G. Holleman, Mandi L. Klamerus, Lillian C. Min, Sandeep Vijan, and Timothy P. Hofer. "Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus." JAMA Internal Medicine (2015): 1-8.

Caverly, Tanner J., Angela Fagerlin, Brian J. Zikmund-Fisher, Susan Kirsh, Jeffrey Todd Kullgren, Katherine Prenovost, and Eve A. Kerr. "Appropriate Prescribing for Patients With Diabetes at High Risk for Hypoglycemia: National Survey of Veterans Affairs Health Care Professionals." JAMA internal medicine (2015): 1-3.

Fri, March 02, 2018

Jeffrey Kullgren was recently interviewed for the US News & World Report article, "Why You Should Talk to Your Doctor About Drug Pricing." According to Dr. Kullgren, "It's important then, especially if a patient's health changes as they age, to periodically be reviewing those medications with their health care team to ensure that they are able to get the medications that are going to be the most beneficial to them, while we avoid prescribing medications to patients who are unlikely to benefit from them and for who those unneeded prescriptions can lead to cost burdens."

The full article can be found below.

Tanner Caverly, MD, MPH


Tanner Caverly has been a general internist and Health Services Research Fellow at the Ann Arbor VA Medical Center and a Clinical Lecturer at the University of Michigan Medical School since July 2013. He graduated from medical school at The Ohio State University School of Medicine and Public Health, and subsequently traveled to the University of Colorado, where he completed internal medicine residency training, a year as Chief Medical Resident, and a Primary Care Research Fellowship / Masters in Public Health.

Last Name: 

Beth A. Tarini, MS, MD


Beth A. Tarini is an Associate Professor of Pediatrics & Division Director of General Pediatrics and Adolescent Medicine at the University of Iowa. Before that, she was an Assistant Professor in the UM Department of Pediatrics and Communicable Diseases. She received her MD from Albert Einstein College of Medicine (2001) and a master's degree from the University of Washington (2006), where she was a Robert Wood Johnson Clinical Scholar. In addition to her clinical interest in preventative care, she pursues an active research program on issues of newborn screening and genetic testing.

Last Name: 

Jeremy Sussman, MD, MS


Dr. Sussman is a Research Scientist in the Center for Clinical Management Research at the Veterans Affairs Ann Arbor Health System and an Assistant Professor in the Department of Internal Medicine at the University of Michigan Medical School. He attended medical school at the University of California, San Francisco, completed internal medicine residency at Yale-New Haven Hospital, and was a Robert Wood Johnson Foundation Clinical Scholar at the University of Michigan.

Last Name: 

Application materials from qualified candidates are now being accepted for the 2012-13 CBSSM post-doctoral research fellow program.  Please see our Post Doc page for more information. 

PIHCD Working Group

Wed, December 03, 2014, 2:00pm

Lauren Wancata and Susanne Warner from Surgery will present about physician and patient understanding of diagnosis and therapeutic options with new diagnosis cancer. The setting is outpatient and the patients first visit with a surgeon.

CBSSM Faculty Dr. Childerhose and Dr. Tarini have published an article in Pediatrics Perspective. This is a commentary that argues for the introduction of adolescent perspectives and experiences into the clinical outcomes evidence base, as an important form of evidence for decision-making. Access the article here

PIHCD: Aaron Scherer

Thu, September 03, 2015, 3:00pm
B004E NCRC Building 16

Aaron Scherer will discuss a project exploring how asking patients to explain how a treatment or screening works might undermine their willingness to use it.

PIHCD: Jon Keevil

Thu, December 03, 2015, 4:00pm
B004E NCRC Building 16

Jon Keevil from Health Decision will be speaking about working with EMRs to incorporate icon arrays for physician-patient communication.